Therapeutics & drug development that raised money in Massachusetts
In the last 30 days, 2 therapeutics & drug development businesses in Massachusetts reported raising $71.3M on SEC Form D. The largest was Typewriter Therapeutics, Inc. ($56.3M).
- New raises
- 9
- Capital reported
- $121M
- Median raise
- $7.1M
Aug 3, 2026 to Oct 16, 2026
sold to investors so far
among raises with sales
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Arkea Bio Corp. | Charlestown, MA | Technology | $15M | $33M | |
| Typewriter Therapeutics, Inc. | Cambridge, MA | Health Care | $56.3M | $56.3M | |
| Animal Biosciences, Inc. | Boston, MA | Other | $2.3M | $2.6M | |
| Aegle Therapeutics Corp | Woburn, MA | Health Care | $2.3M | $2.3M | |
| Platform Therapeutics, Inc. | Andover, MA | Health Care | $1.8M | $4M | |
| Unravel Biosciences, Inc. | Medford, MA | Health Care | $4.1M | $4.5M | |
| Outer Biosciences Inc | Malden, MA | Other | $23.3M | $23.3M | |
| Hyku Biosciences Inc. | Concord, MA | Health Care | $8.6M | $8.6M | |
| Auron Therapeutics, Inc. | Wellesley, MA | Health Care | $7.1M | $12M |
Therapeutics & drug development nationwide · All raises in Massachusetts · Filter these →